Another relevant finding was the increased co-expression of IFN-γ and granulocyte-macrophage colony-stimulating factor (GM-CSF) in the CD4+ T cells of COVID-19 patients with severe disease progression [101]. The gene discussed is CSF2; the disease is COVID-19.